[1] Cao MM, Chen WQ.Epidemiology of cancer in China and the current status of prevention and control[J]. Chinese Journal of Clinical Oncology(中国肿瘤临床), 2019, 46(3): 145-149. [2] Xu JY, Huang YY.Research progress of toxic traditional Chinese medicine in treating malignant tumor[J]. Chinese Journal of Ethnomedicine and Ethnopharmacy(中国民族民间医药), 2017, 26(21): 53-58. [3] Gu XD, Xu LL, Zhao H, et al.Cantharidin suppressed breast cancer MDA-MB-231 cell growth and migration by inhibiting MAPK signaling pathway[J]. Brazilian Journal of Medical Biological Research, 2017, 50(7): e5920. [4] Huang G, Yang L, Zhou W, et al.Study on cardiotoxicity and mechanism of "fuzi" extracts based on metabonomics[J]. Interna-tional Journal of Molecular Sciences, 2018, 19(11): 3506. [5] Xu XL, Yang LJ, Jiang JG.Renal toxic ingredients and their toxicology from traditional Chinese medicine[J]. Expert Opinion on Drug Metabolism & Toxicology, 2016, 12(2): 149-59. [6] Zhang XM, Lin ZJ, Zhang B, et al.Comparison of aconitum with tripterygium in treatment of axial spondyloarthritis: a benefit-risk assessment[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018, 15(2): 103-109. [7] Zhang XM, Jin YN, Zhang B, et al.Aconitum in treatment of rheumatoid arthritis: benefit-risk assessment[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2018, 43(2): 234-241. [8] Wang D, Jia DX, Li ZZ, et al.Safety evaluation and risk control measures for Aconiti Kusnezoffii Radix[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2018, 43(15): 3093-3100. [9] Zhang XM, Lin ZJ, Zhang B, et al.Risk-benefit assessment of aconitum napellus[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2018, 33(6): 2221-2224. [10] Zhang XM, Li F, Zhang B, et al.Data-mining characteristics of adverse drug reactions and pharmacovigilance of Chinese patent drugs including aconitum herbs[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2018, 43(2): 234-241. [11] Song LJ, Ji XM, Wang HR, et al.Review on treating tumor by wen yang method[J]. Information on Traditional Chinese Medicine(中医药信息), 2015, 32(1): 118-121. [12] Ng AWT, Poon SL, Huang MN, et al. Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throug-hout Asia[J]. Science Translational Medicine, 2017, 9(412): eaan 6446. [13] Zhang JL, Mao R, Du G.Research advance on alkaloids and their pharmacological effects of Radix Aconite[J]. Herald of Medicine(医药导报), 2019, 38(8): 1048-1051. [14] Sanguinetti A, Santini D, Bonafè M, et al.Interleukin-6 and pro inflammatory status in the breast tumor microenvironment[J]. World Journal of Surgical Oncology, 2015, 13(1): 129. [15] Zhang W, Sun HC, Wang WQ, et al.Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotropic hepatocellular carcinoma tumors in mice[J].Gastroenterology, 2012, 143(6): 1641-1649. [16] Jing CP, He JZ, Wei XL.Inflammatory cytokines IL-1beta, IL-8, the relationship between the TNF-alpha and breast cancer[J]. Journal of Yanan University(Medical Science Edition)(延安大学学报(医学科学版)), 2014, 12(3): 61-63. [17] Wang M.Research progress of aldosterone and its receptor antagonists in cardiovascular disease[J]. Journal of Mathematical Medicine(数理医药学杂志), 2017, 30(4): 592-594. [18] Peng HW, Shi RZ, Yuan XF, et al.The anti-apoptotic effect of c-fos in drug-resistant breast cancer cells[J]. China Oncology(中国癌症杂志), 2014, 24(8): 581-588. [19] Zhang YD, Zhu PF, Wang ZG, et al.Effect of severe traumatic injury on expression of c-fos and corticotropin-releasing hormone in the hypothalamus of rats[J]. Journal of Third Military Medical University(第三军医大学学报), 2003, 25(11): 965-967. [20] Wei R, Wong JPC, Kwok HF.Osteopontin - a promising biomarker for cancer therapy[J]. Journal of Cancer, 2017, 8(12): 2173-2183. [21] Li TQ, Teng YL, Zou YG, et al.The highly expressed secreted phosphoprotein 1 gene in prostate cancer metastasis: a microarray-based bioinformatics analysis[J]. National Journal of Andrology(中华男科学杂志), 2014, 20(11): 984-990. [22] Zhong JQ, Wang YT, Chen YM, et al.Expression and significance of osteopontin in lung cancer[J]. Chongqing Medicine(重庆医学), 2019, 48(10): 118-120. [23] Gong FH, Yang B, Sun SH, et al.Study on the expression difference of SPP1 in different CRC cell lines and the regulation mechanism of EMT[J]. Journal of Ningxia Medical University(宁夏医科大学学报), 2019, 41(6): 584-588. [24] Wan XJ, Yi ZH, Fang YR, et al.Association study between BTRK2 gene polymorphisms and schizophrenia in Chinese Han people[J]. General Psychiatry(上海精神医学), 2008, 20(2): 72-74,81. [25] Liang XY, Ma SJ, Wang Y, et al.The expressions of Runx2 and OPN protein inhuman breast cancer tissue and their association with microcalcofication[J]. Journal of Xi'an Jiaotong University(Medical Sciences)(西安交通大学学报(医学版)), 2014(6): 828-831. [26] Lin MZ, Wang HD, Wu N, et al.The expression and clinical significance of CXCR3 in human breast cancer[J]. Acta Academiae Medicinae Weifang(潍坊医学院学报), 2014(5): 327-329. [27] Chen YB, Lin Z.The relationship between the expression of intercellular adhesion molecule (ICAM) and its invasion and metastasis in breast cancer[J]. Chinese Geriatrics, 1998, 18(4): 215-216. [28] Pan LZ, Yan ZY, Zuo CY, et al.Influence of long-term usage of diazepam on neuroactive ligand-receptor interaction signaling pathway[J]. Journal of China Pharmaceutical University(中国药科大学学报), 2011, 42(5): 443-446. [29] Pan XQ, Peng C.Research progress on neurotoxicity of radix aconiti lateralis preaparta[J]. World Chinese Medicine(世界中医药), 2017, 12(11): 2551-2554, 2562. |